Patients
Pustular Psoriasis, PGA‐GPP, Psoriasis, tumor necrosis
ERYTHRODERMIC PSORIASIS, TUMOR NECROSIS, PSORIASIS, DISEASE, GENERALIZED PUSTULAR PSORIASIS
A total of 17 patients, including eight patients with GPP and nine patients with EP, were enrolled and 10 (58.8%) patients completed the study Patient disposition. Baseline demographics and disease characteristicsAbbreviations: BMI, body mass index; BSA, body surface area; DLQI 0/1, Dermatology Life Quality Index of 0 or 1 (no effect); EP, erythrodermic psoriasis; JDA, Japanese Dermatological Association; NA, not applicable; PASI, Psoriasis Area and Severity Index; PGA‐GPP, Physician's Global Assessment of Generalized Pustular Psoriasis; SD, standard deviation; TNFi, tumor necrosis factor α inhibitor.Only applicable to patients with generalized pustular psoriasis (GPP).